Willis Investment Counsel reduced its stake in Labcorp Holdings Inc. by 7.2% in the 3rd quarter, selling 4,728 shares and now owning 61,178 shares valued at $17.56 million. Other institutional investors also adjusted their positions in the medical research company, while CEO Adam H. Schechter sold 5,745 shares for over $1.5 million. Analysts have set an average target price of $300.58 for Labcorp, with a “Moderate Buy” consensus rating.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Willis Investment Counsel Sells 4,728 Shares of Labcorp Holdings Inc. $LH
Willis Investment Counsel reduced its stake in Labcorp Holdings Inc. by 7.2% in the 3rd quarter, selling 4,728 shares and now owning 61,178 shares valued at $17.56 million. Other institutional investors also adjusted their positions in the medical research company, while CEO Adam H. Schechter sold 5,745 shares for over $1.5 million. Analysts have set an average target price of $300.58 for Labcorp, with a “Moderate Buy” consensus rating.